SynDermix AG is a Swiss developer of innovative health technologies funded by private investors. The
Company focuses on the development of effective and safe treatments that meaningfully respect
patient convenience and address important unmet medical needs.
We are interested in partnerships for the further development of the products in our portfolio and/or their commercialisation.